Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 6:04 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 793–816 of 1,743 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiovascular Risks Clear all

Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: clarithromycin, prasterone; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2006
U.S. locations: 3
States / cities: Scottsdale, Arizona • Jacksonville, Florida • Rochester, Minnesota

Conditions: Atrial Fibrillation
Interventions: Warfarin; Drug
Lead sponsor: Robert Stein; Other
Eligibility: 70 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Rockport, Maine

Conditions: HIV-1-infection, Coronary Microvascular Dysfunction, Metabolic Disease
Interventions: Health Education, Subspecialty clinic referral; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 45 Years to 75 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obesity, Inflammation
Interventions: high protein diet, high carbohydrate diet; Dietary Supplement
Lead sponsor: University of Tennessee; Other
Eligibility: 20 Years to 50 Years · Female only
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Atrial Fibrillation New Onset
Interventions: Self-Pulse Monitoring; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 526 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Cancer
Interventions: acupuncture therapy, management of therapy complications, pain therapy; Procedure
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cardiovascular Diseases
Interventions: Evacetrapib, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 12,092 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 176
States / cities: Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 173 more

Conditions: Coronary Artery Disease (CAD)
Interventions: XC001, A195/placebo; Drug
Lead sponsor: XyloCor Therapeutics, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 116 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Atherosclerosis
Interventions: Vitamin D3; Dietary Supplement
Lead sponsor: Rockefeller University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Cardiovascular Disease, Hyperlipidemia
Interventions: Avocado Diet, Lower-Fat Diet, Moderate Fat Diet; Other
Lead sponsor: Penn State University; Other
Eligibility: 21 Years to 70 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Myeloma Multiple
Interventions: Descartes 08; Biological
Lead sponsor: Cartesian Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Orange, California • Nashville, Tennessee

Conditions: Type 2 Diabetes, Cardiovascular Risk
Interventions: Zenagamtide, Insulin glargine U-100; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 45 Years and older
Enrollment: 1,778 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 109
States / cities: Birmingham, Alabama • Fairhope, Alabama • Montgomery, Alabama + 91 more

Conditions: Carotid Artery Plaque, Arteriosclerosis, Obesity, Metabolic Syndrome X
Interventions: Rimonabant, Placebo (for Rimonabant); Drug
Lead sponsor: Sanofi; Industry
Eligibility: 55 Years and older
Enrollment: 661 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Elevated Blood Pressure, Habitual Sleep Duration of Less Than or Equal to 7 Hours
Interventions: Sleep extension intervention, Health education; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 65 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Hypertension (HTN)
Interventions: Dyadic lifestyle intervention for CVD risk reduction; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Coronary Artery Bypass
Interventions: Atrial Fibrillation; Procedure
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 3
States / cities: Atlanta, Georgia • Decatur, Georgia

Conditions: Childhood Obesity, Pediatric Obesity, Quality of Life, Cardiovascular Risk Factor
Interventions: Hearts & Parks; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 5 Years to 18 Years
Enrollment: 327 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 3
States / cities: Durham, North Carolina

Conditions: Nutrition, Healthy, Maternal Behavior, Health Behavior
Interventions: Not listed
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 89 Years
Enrollment: 115 participants
Timeline: 2023
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Premature Endothelial Dysfunction, Rheumatoid Arthritis, Healthy
Interventions: Not listed
Lead sponsor: Orrin M Troum, M.D. and Medical Associates; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: High-risk Smoldering Multiple Myeloma, Smoldering Multiple Myeloma, Multiple Myeloma
Interventions: Teclistamab, Lenalidomide, Dexamethasone; Drug
Lead sponsor: Irene Ghobrial, MD; Other
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2030
U.S. locations: 3
States / cities: Denver, Colorado • Boston, Massachusetts • Portland, Oregon

Conditions: Cardiovascular Risk Factor
Interventions: Care4U; Behavioral
Lead sponsor: University of Nebraska; Other
Eligibility: 65 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: Coronary Artery Disease, Polygenic Risk Score, Heart Diseases, Coronary Disease, Myocardial Infarction, Cardiovascular Diseases
Interventions: Disclosure of integrate risk score for coronary artery disease; Genetic
Lead sponsor: MyOme; Industry
Eligibility: 40 Years to 70 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: Rochester, Minnesota • Philadelphia, Pennsylvania

Conditions: Cardiovascular Disease
Interventions: Controlled diet with whole grain barley, whole grain oats, or low grain diet; Other
Lead sponsor: United States Department of Agriculture (USDA); Federal
Eligibility: 25 Years to 70 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Beltsville, Maryland

Conditions: Cardiovascular Disease
Interventions: CVD risk reduction program; Behavioral
Lead sponsor: Denver Health and Hospital Authority; Other
Eligibility: 30 Years to 64 Years
Enrollment: 340 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Denver, Colorado

Search by objective public record fields.

Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma

Anticoagulation Therapy in the Very Old

Improving Coronary Vascular Health in Women

Effect of Diet Composition on Weight Change and Metabolic Parameters

Screening for Atrial Fibrillation With Self Pulse Monitoring

Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation

A Study of Evacetrapib in High-Risk Vascular Disease

Epicardial Delivery of XC001 Gene Therapy to Promote Angiogenesis in CAD Patients Undergoing Treatment With CABG

The Effect of Vitamin D Repletion on Small Low Density Lipoprotein (LDL) Particle Number in Subjects at Elevated Cardiovascular Risk

The Effect of Avocado on Cardiovascular Disease (CVD) Risk Factors

Descartes-08 Consolidation Treatment in Patients With High-Risk Multiple Myeloma High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant

Sleep Technology Intervention to Target Cardiometabolic Health

Assessing the Feasibility of the "Heart Care Pairs" Intervention

A Retrospective Analysis of the Predictive Potential of Pre-operative

A Trial of an Integrated Clinic-community Intervention in Children and Adolescents With Obesity (Hearts and Parks)

Improving the Cardiovascular Health of High-Risk Families Through an Innovative Home Visitation Intervention

Exploratory Trial to Evaluate Premature Endothelial Dysfunction in Early Rheumatoid Arthritis(RA)Compared to Patients With Established RA, and Normal Subjects

Immuno-PRISM (PRecision Intervention Smoldering Myeloma)

Care4U: Self Management Intervention for Older Adult Caregivers

Utility and Effectiveness of Polygenic Risk Scoring (PRS) for Coronary Artery Disease (CAD)

Acute Heart Health Benefits of Whole Grain Barley and Oats in Healthy Men and Women

Denver Health Cardiovascular Disease (CVD) Prevention Program